157 related articles for article (PubMed ID: 34779916)
1. Depressive symptoms in patients after primary and secondary prophylactic ICD implantation.
Ensslin C; Berg J; Hermes-Laufer J; Keller LS; Niederseer D; Pazhenkottil A; von Känel R; Schmied C
Clin Res Cardiol; 2022 Nov; 111(11):1210-1218. PubMed ID: 34779916
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review.
Magyar-Russell G; Thombs BD; Cai JX; Baveja T; Kuhl EA; Singh PP; Montenegro Braga Barroso M; Arthurs E; Roseman M; Amin N; Marine JE; Ziegelstein RC
J Psychosom Res; 2011 Oct; 71(4):223-31. PubMed ID: 21911099
[TBL] [Abstract][Full Text] [Related]
3. Implantable Cardioverter Defibrillator Shocks and Psychological Distress: Examining the Mediating Roles of Implantable Cardioverter Defibrillator-Related Concerns and Perceived Control.
Lee KS; Hammash MH; Kim JH; Kang KW; Miller J; McEvedy SM; Hwang SY; Moser DK
J Cardiovasc Nurs; 2020; 35(1):66-73. PubMed ID: 31441803
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death.
Verkerk AJ; Vermeer AM; Smets EM; Dekker LR; Wilde AA; Van Langen IM; Christiaans I; Nieuwkerk PT
Pacing Clin Electrophysiol; 2015 Jul; 38(7):870-7. PubMed ID: 25880250
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
6. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.
Kamphuis HC; de Leeuw JR; Derksen R; Hauer RN; Winnubst JA
Europace; 2003 Oct; 5(4):381-9. PubMed ID: 14753636
[TBL] [Abstract][Full Text] [Related]
8. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
[TBL] [Abstract][Full Text] [Related]
9. Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients.
Ghezzi ES; Sharman RLS; Selvanayagam JB; Psaltis PJ; Sanders P; Astley JM; Knayfati S; Batra V; Keage HAD
Europace; 2023 Jun; 25(6):. PubMed ID: 37311667
[TBL] [Abstract][Full Text] [Related]
10. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.
Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R
Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818
[TBL] [Abstract][Full Text] [Related]
11. Both mental and physical health predicts one year mortality and readmissions in patients with implantable cardioverter defibrillators: findings from the national DenHeart study.
Berg SK; Rasmussen TB; Mols RE; Thorup CB; Borregaard B; Christensen AV; Cromhout PF; Ekholm O; Juel K; Thrysoee L
Eur J Cardiovasc Nurs; 2019 Feb; 18(2):96-105. PubMed ID: 30114937
[TBL] [Abstract][Full Text] [Related]
12. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
13. Sudden cardiac death and implantable cardioverter-defibrillators.
Turakhia MP
Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
[TBL] [Abstract][Full Text] [Related]
15. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
16. Contemporary benefit-harm profile over two decades in primary prophylactic ICD-therapy.
Kleemann T; Strauss M; Kouraki K; Lampropoulou E; Fendt A; Werner N; Zahn R
Clin Cardiol; 2019 Oct; 42(10):866-872. PubMed ID: 31317573
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients admitted with ventricular arrhythmias and sudden cardiac death in the United States.
Viles-Gonzalez JF; Arora S; Deshmukh A; Atti V; Agnihotri K; Patel N; Dave M; Anter E; Garcia F; Santangeli P; Goldberger JJ; Dukkipati S; d'Avila A; Natale A; Di Biase L
Heart Rhythm; 2019 Mar; 16(3):358-366. PubMed ID: 30236610
[TBL] [Abstract][Full Text] [Related]
19. Association of psychiatric history and type D personality with symptoms of anxiety, depression, and health status prior to ICD implantation.
Starrenburg AH; Kraaier K; Pedersen SS; van Hout M; Scholten M; van der Palen J
Int J Behav Med; 2013 Sep; 20(3):425-33. PubMed ID: 22821676
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
